沙美特罗替卡松气雾剂联合孟鲁司特治疗咳嗽变异性哮喘疗效观察

摘要

Objective To Observe the clinical effect of cough variant asthma treated with seretide combined with Montelukast. Methods 44 cases of cough variant asthma were selected in our hospital from November 2010 to November 2015, all the patients were randomly divided into the single group and the combination group, there were 22 cases in each group. The single group patients were given seretide inhalation therapy, the combination group patients were given montelukast on the basis of seretide, the.clinical efifcacy and clinical symptoms disappeared time of two groups were statistically analyzed.ResultsThe clinical total effective rate of the single group(59.1%) was signiifcant lower than that of the combination group(95.5%), and the difference was signiifcant between two groups (P<0.05); The clinical symptoms disappeared time of the single group (9.96 ± 1.85) d was signiifcant longer than that of the combination group (6.83 ± 1.71) d, and the difference between the two groups was signiifcantP<0.05).Conclusion The clinical effect of the cough variant asthma patients treated with seretide joint montelukast is better, and it also can short the clinical symptoms disappeared time, the clinical treatment is worth popularization and application.%目的：观察舒利迭联合孟鲁司特治疗咳嗽变异性哮喘的临床疗效。方法将我院2010年11月～2015年11月收治的44例咳嗽变异性哮喘患者作为研究对象，随机分为单一组与联合组，各22例。单一组应用舒利迭吸入治疗，联合组于此基础上加入孟鲁司特治疗。统计两组患者临床效果及临床症状消失时间。结果单一组临床总有效率（59.1%）低于联合组（95.5%），两组差异显著（P＜0.05）；单一组临床症状消失时间（9.96±1.85）d长于联合组（6.83±1.71）d，两组差异显著（P＜0.05）。结论舒利迭联合孟鲁司特治疗咳嗽变异性哮喘，临床效果较好，可缩短患者的症状消失时间，临床治疗中值得推广应用。